基于丝复合材料的多功能颗粒用于控制释放
Sushma Indrakumar1, Sriram Bharath Gugulothu1, Akshat Joshi1
1Department of Materials Engineering, Indian Institute of Science, Bangalore, 560012, India.
Macromolecular bioscience
|October 20, 2024
概括
一种新的丝/生物陶复合物药物输送系统可以增强慢性伤口愈合. 这种多功能平台为医疗点治疗提供抗氧化和抗菌特性,改善患者的治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 药物输送系统 药物输送系统
背景情况:
- 由于感染和炎症,慢性伤口带来了重大的临床挑战.
- 现有的护理点治疗因复杂的制造而受到限制,缺乏必要的治疗特性.
- 硫酸半 (CSH) 平台提供快速制造,但缺乏抗氧化和抗菌功能.
研究的目的:
- 设计一个用于慢性伤口管理的多功能药物输送平台.
- 开发一种用于护理场所应用的丝/生物陶复合材料.
- 通过结合抗氧化剂和抗菌功能来增强治疗性质.
主要方法:
- 设计了一种酸 (TA) - 丝纤维素 (SF) 复合物,作为CSH水泥的添加剂.
- 制造的丝/生物陶基复合颗粒用于药物输送.
- 将TA-SF复合体纳入CSH,以创建多功能颗粒.
- 在动物模型中评估了抗氧化活性,抗菌疗效和体内毒性.
主要成果:
- 与整洁的CSH相比,复合颗粒显示抗氧化活性增加了7.5倍.
- 长时间的抗菌疗效被观察到长达13天.
- 在动物模型中,皮下植入没有显示出局部或全身毒性的迹象.
- 优化了对潜在市场翻译的构成和制造.
结论:
- 开发的多功能丝/生物陶系统为慢性伤口愈合提供了增强的抗氧化和抗菌特性.
- 这个平台为个性化,即时治疗提供了一个有前途的解决方案.
- 复合颗粒在伤床和骨腔中有潜在的应用,用于治疗治疗.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...


